Literature DB >> 23764790

Pathologic hip morphology in cerebral palsy and Down syndrome.

Jonathan G Schoenecker1.   

Abstract

The pathogenesis and clinical course of hip dysplasia in cerebral palsy and Down syndrome is different than idiopathic developmental dysplasia of the hip. Unlike idiopathic developmental hip dysplasia, hip development in cerebral palsy and Down syndrome is typically normal in utero and instability develops after birth secondary to musculoskeletal disorders associated with the disease condition. For this reason, treatment protocols in Down syndrome and cerebral palsy hip dysplasia differ greatly from protocols designed to treat idiopathic hip dysplasia. The purpose of this review is to describe the pathologic hip morphology that results from cerebral palsy and Down syndrome.

Entities:  

Mesh:

Year:  2013        PMID: 23764790     DOI: 10.1097/BPO.0b013e3182860034

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  4 in total

1.  Does hemipelvis structure and position influence acetabulum orientation?

Authors:  Bartosz Musielak; Marek Jóźwiak; Michał Rychlik; Brian Po-Jung Chen; Maciej Idzior; Andrzej Grzegorzewski
Journal:  BMC Musculoskelet Disord       Date:  2016-03-16       Impact factor: 2.362

2.  Effect of the Sharrard procedure on hip instability in children with Down syndrome: a retrospective study.

Authors:  Frederike E C M Mulder; Levinus A Bok; Florens Q M P van Douveren; Hans E H Pruijs; Adelgunde V C M Zeegers
Journal:  J Child Orthop       Date:  2021-10-01       Impact factor: 1.548

3.  Preliminary results of an anteverting triple periacetabular osteotomy for the treatment of hip instability in Down syndrome.

Authors:  D A Maranho; Y-J Kim; K A Williams; E N Novais
Journal:  J Child Orthop       Date:  2018-02-01       Impact factor: 1.548

4.  Femoral and Dega osteotomies in the treatment of habitual hip dislocation in Down syndrome patients - is it efficient or not?

Authors:  Ahmad S Aly; Mohamed A Al-Kersh
Journal:  J Child Orthop       Date:  2018-06-01       Impact factor: 1.548

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.